\-\ Texto\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ no\\ current\\ physical\\ exam\\ findings\ \(0\)\
\-\ \\â\\€\\¢\\ lp\\:\\ 5\\ oligoclonal\\ bands\\ on\\ csf\\,\\ lumbar\\ puncture\\ sampling\ \(0\)\
\-\ \\â\\€\\¢\\ patient\\ will\\ continue\\ to\\ follow\\-up\\ with\\ neurology\ \(0\)\
\-\ \\â\\€\\¢\\ repeat\\ scans\\ will\\ be\\ performed\\ when\\ clinically\\ indicated\ \(0\)\
\-\ within\\ the\\ right\\ corona\\ radiata\\,\\ there\\ is\\ continued\\ presence\\ of\\ a\\ t2\\ and\\ flair\\ hyperintense\\ lesion\\,\\ which\\ displays\\ interval\\ slight\\ decrease\\ in\\ size\\ and\\ clarity\\ of\\ margins\\.\\ \\ additionally\\,\\ there\\ is\\ no\\ longer\\ post\\-contrast\\ enhancement\\ of\\ the\\ lesion\\.\\ \\ gray\\ matter\\/white\\ matter\\ differentiation\\ is\\,\\ otherwise\\,\\ preserved\\ throughout\\.\ \(0\)\
\-\ prior\\ study\\ dated\\ 1\\ week\\ earlier\\ shows\\ t2\\ high\\ signal\\ within\\ the\\ corona\\ radiata\\ and\\ a\\ smoothly\\ uniform\\ enhancement\\ pattern\\ likely\\ represent\\ a\\ demyelinating\\ plaque\\ \\(tumefactive\\ multiple\\ sclerosis\\)\\.\ \(0\)\
\-\ tumefactive\\ multiple\\ sclerosis\ \(2\)\
\-\ \\â\\€\\¢\\ tumefactive\\ ms\ \(0\)\
\-\ \\â\\€\\¢\\ gbm\ \(0\)\
\-\ \\â\\€\\¢\\ primary\\ cns\\ lymphoma\ \(0\)\
\-\ 20\\ year\\-old\\ woman\\ with\\ left\\ side\\ upper\\ and\\ lower\\ weakness\\ 3\\ weeks\\ ago\\.\\ now\\ asymptomatic\\.\\ seen\\ by\\ hometown\\ er\\,\\ ct\\ scan\\ negative\\.\\ evaluated\\ by\\ mri\\ 1\\ week\\ ago\\ which\\ demonstrated\\ an\\ enhancing\\ brain\\ lesion\\.\\ \\ please\\ reevaluate\\.\ \(0\)\
\-\ this\\ case\\ is\\ interesting\\ because\\ the\\ follow\\-up\\ study\\ was\\ performed\\ a\\ week\\ after\\ the\\ initial\\ study\\,\\ which\\ was\\ 5\\ weeks\\ earlier\\ than\\ originally\\ planned\\.\\ \\ the\\ patient\\ was\\ able\\ to\\ schedule\\ the\\ repeat\\ exam\\ due\\ to\\ an\\ opening\\ in\\ the\\ schedule\\ and\\ did\\ so\\ shortly\\ after\\ the\\ order\\ was\\ submitted\\.\\ \\ the\\ dramatic\\ lesion\\ enhancement\\ on\\ the\\ original\\ study\\ has\\ resolved\\ which\\ appears\\ to\\ signal\\ radiographic\\ correlation\\ with\\ resolution\\ of\\ clinical\\ signs\\ and\\ symptoms\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ tumefactive\\:\\ 0\\.2604583493986344\ \(0\)\
\-\ radiata\\:\\ 0\\.21076638113574792\ \(0\)\
\-\ corona\\:\\ 0\\.20719016784853073\ \(0\)\
\-\ schedule\\:\\ 0\\.20719016784853073\ \(0\)\
\-\ study\\:\\ 0\\.20377746854494203\ \(0\)\
\-\ the\\:\\ 0\\.1676608700068673\ \(0\)\
\-\ week\\:\\ 0\\.1541339508716776\ \(0\)\
\-\ lesion\\:\\ 0\\.14648576747185582\ \(0\)\
\-\ earlier\\:\\ 0\\.1395465661444811\ \(0\)\
\-\ which\\:\\ 0\\.13893501301009367\ \(0\)\
\-\ repeat\\:\\ 0\\.1340023505960356\ \(0\)\
\-\ enhancement\\:\\ 0\\.1319004153154085\ \(0\)\
\-\ hometown\\:\\ 0\\.12215882469259451\ \(0\)\
\-\ clarity\\:\\ 0\\.11672927858130397\ \(0\)\
\-\ reevaluate\\:\\ 0\\.11672927858130397\ \(0\)\
\-\ matter\\:\\ 0\\.11632403978226931\ \(0\)\
\-\ ago\\:\\ 0\\.11178086887708398\ \(0\)\
\-\ dated\\:\\ 0\\.1098888594586644\ \(0\)\
\-\ sclerosis\\:\\ 0\\.10881704391773801\ \(0\)\
\-\ was\\:\\ 0\\.10648596452519374\ \(0\)\
\-\ oligoclonal\\:\\ 0\\.09933069918968704\ \(0\)\
\-\ will\\:\\ 0\\.09832893644194107\ \(0\)\
\-\ sampling\\:\\ 0\\.09709369324855897\ \(0\)\
\-\ and\\:\\ 0\\.09470615111768269\ \(0\)\
\-\ lp\\:\\ 0\\.0920119824956492\ \(0\)\
\-\ weeks\\:\\ 0\\.0915599923852417\ \(0\)\
\-\ displays\\:\\ 0\\.09067177407241883\ \(0\)\
\-\ performed\\:\\ 0\\.09038114022624402\ \(0\)\
\-\ smoothly\\:\\ 0\\.08888366742881022\ \(0\)\
\-\ t2\\:\\ 0\\.08789465483359062\ \(0\)\
\-\ dramatic\\:\\ 0\\.0868194497995448\ \(0\)\
\-\ signal\\:\\ 0\\.08660279906074946\ \(0\)\
\-\ demyelinating\\:\\ 0\\.08383135494977927\ \(0\)\
\-\ is\\:\\ 0\\.08367597251262456\ \(0\)\
\-\ puncture\\:\\ 0\\.08345412131751968\ \(0\)\
\-\ opening\\:\\ 0\\.08345412131751968\ \(0\)\
\-\ bands\\:\\ 0\\.08107480895345362\ \(0\)\
\-\ original\\:\\ 0\\.08107480895345362\ \(0\)\
\-\ neurology\\:\\ 0\\.08076695842135788\ \(0\)\
\-\ gbm\\:\\ 0\\.08076695842135788\ \(0\)\
\-\ interesting\\:\\ 0\\.08076695842135788\ \(0\)\
\-\ submitted\\:\\ 0\\.08076695842135788\ \(0\)\
\-\ preserved\\:\\ 0\\.08017170894173534\ \(0\)\
\-\ plaque\\:\\ 0\\.08017170894173534\ \(0\)\
\-\ uniform\\:\\ 0\\.0798837213181617\ \(0\)\
\-\ planned\\:\\ 0\\.07827487984669843\ \(0\)\
\-\ shortly\\:\\ 0\\.07827487984669843\ \(0\)\
\-\ longer\\:\\ 0\\.07777886357159235\ \(0\)\
\-\ originally\\:\\ 0\\.07777886357159235\ \(0\)\
\-\ exam\\:\\ 0\\.07690611906880067\ \(0\)\
\-\ to\\:\\ 0\\.07638601349743938\ \(0\)\
\-\ correlation\\:\\ 0\\.07617461668187715\ \(0\)\
\-\ continue\\:\\ 0\\.07493765401585521\ \(0\)\
\-\ multiple\\:\\ 0\\.07472471046312955\ \(0\)\
\-\ differentiation\\:\\ 0\\.07417225093335511\ \(0\)\
\-\ ms\\:\\ 0\\.07417225093335511\ \(0\)\
\-\ after\\:\\ 0\\.07411279699437491\ \(0\)\
\-\ cns\\:\\ 0\\.07133377672812762\ \(0\)\
\-\ order\\:\\ 0\\.07060185093399711\ \(0\)\
\-\ within\\:\\ 0\\.07036263754417327\ \(0\)\
\-\ interval\\:\\ 0\\.06911993845432414\ \(0\)\
\-\ resolved\\:\\ 0\\.0686192854380452\ \(0\)\
\-\ able\\:\\ 0\\.0670011752980178\ \(0\)\
\-\ current\\:\\ 0\\.06689274629771258\ \(0\)\
\-\ slight\\:\\ 0\\.06689274629771258\ \(0\)\
\-\ scans\\:\\ 0\\.06646760238760706\ \(0\)\
\-\ decrease\\:\\ 0\\.06565578363169064\ \(0\)\
\-\ gray\\:\\ 0\\.06536360676723395\ \(0\)\
\-\ evaluated\\:\\ 0\\.0652676141814501\ \(0\)\
\-\ margins\\:\\ 0\\.06517230482270657\ \(0\)\
\-\ flair\\:\\ 0\\.0649836973614869\ \(0\)\
\-\ by\\:\\ 0\\.06487637278854981\ \(0\)\
\-\ so\\:\\ 0\\.06425476049822113\ \(0\)\
\-\ please\\:\\ 0\\.0640785617932741\ \(0\)\
\-\ represent\\:\\ 0\\.06356346335124329\ \(0\)\
\-\ clinically\\:\\ 0\\.06347950753784151\ \(0\)\
\-\ additionally\\:\\ 0\\.06290610887901532\ \(0\)\
\-\ indicated\\:\\ 0\\.06282616291992509\ \(0\)\
\-\ continued\\:\\ 0\\.06258914950473894\ \(0\)\
\-\ resolution\\:\\ 0\\.06197688705322637\ \(0\)\
\-\ lumbar\\:\\ 0\\.06168094333151993\ \(0\)\
\-\ there\\:\\ 0\\.06078799304135186\ \(0\)\
\-\ hyperintense\\:\\ 0\\.06076194529065967\ \(0\)\
\-\ csf\\:\\ 0\\.06035816871933611\ \(0\)\
\-\ of\\:\\ 0\\.059794088777717296\ \(0\)\
\-\ an\\:\\ 0\\.058419969325520966\ \(0\)\
\-\ er\\:\\ 0\\.057133525666855534\ \(0\)\
\-\ pattern\\:\\ 0\\.05702971965575612\ \(0\)\
\-\ radiographic\\:\\ 0\\.05667260760259948\ \(0\)\
\-\ throughout\\:\\ 0\\.05617842206211563\ \(0\)\
\-\ appears\\:\\ 0\\.055938004322931625\ \(0\)\
\-\ weakness\\:\\ 0\\.05574873038209938\ \(0\)\
\-\ presence\\:\\ 0\\.05488450095899089\ \(0\)\
\-\ did\\:\\ 0\\.054796691409109526\ \(0\)\
\-\ otherwise\\:\\ 0\\.054451100399744885\ \(0\)\
\-\ because\\:\\ 0\\.05338581839776052\ \(0\)\
\-\ signs\\:\\ 0\\.05338581839776052\ \(0\)\
\-\ side\\:\\ 0\\.052770035959798456\ \(0\)\
\-\ now\\:\\ 0\\.052435710202421396\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.052002543323049995\ \(0\)\
\-\ size\\:\\ 0\\.05172135906270721\ \(0\)\
\-\ initial\\:\\ 0\\.05124306149130894\ \(0\)\
\-\ patient\\:\\ 0\\.0496894614722987\ \(0\)\
\-\ no\\:\\ 0\\.04968011517426394\ \(0\)\
\-\ 20\\:\\ 0\\.049279907801182195\ \(0\)\
\-\ clinical\\:\\ 0\\.04841024485867539\ \(0\)\
\-\ enhancing\\:\\ 0\\.047851655282690954\ \(0\)\
\-\ brain\\:\\ 0\\.047619213235580264\ \(0\)\
\-\ negative\\:\\ 0\\.04729043031965448\ \(0\)\
\-\ primary\\:\\ 0\\.046969526836064805\ \(0\)\
\-\ demonstrated\\:\\ 0\\.046945157569333075\ \(0\)\
\-\ when\\:\\ 0\\.046141934668022355\ \(0\)\
\-\ on\\:\\ 0\\.04614013697469756\ \(0\)\
\-\ likely\\:\\ 0\\.04564675222388098\ \(0\)\
\-\ lymphoma\\:\\ 0\\.045492958312540174\ \(0\)\
\-\ scan\\:\\ 0\\.04531932983953453\ \(0\)\
\-\ with\\:\\ 0\\.04487236179863538\ \(0\)\
\-\ shows\\:\\ 0\\.044832334048685626\ \(0\)\
\-\ due\\:\\ 0\\.043908456828185526\ \(0\)\
\-\ high\\:\\ 0\\.04341314628489722\ \(0\)\
\-\ than\\:\\ 0\\.04330139953037473\ \(0\)\
\-\ prior\\:\\ 0\\.042738444551810244\ \(0\)\
\-\ symptoms\\:\\ 0\\.04179442795100695\ \(0\)\
\-\ physical\\:\\ 0\\.04141857546550465\ \(0\)\
\-\ upper\\:\\ 0\\.04081982335491515\ \(0\)\
\-\ woman\\:\\ 0\\.039782398161793915\ \(0\)\
\-\ mri\\:\\ 0\\.039210109672564976\ \(0\)\
\-\ lower\\:\\ 0\\.03903364304496066\ \(0\)\
\-\ case\\:\\ 0\\.03837580407950301\ \(0\)\
\-\ in\\:\\ 0\\.038005020848602925\ \(0\)\
\-\ findings\\:\\ 0\\.03769985773600032\ \(0\)\
\-\ seen\\:\\ 0\\.03596219923429192\ \(0\)\
\-\ has\\:\\ 0\\.034891179410945744\ \(0\)\
\-\ be\\:\\ 0\\.030986995400439296\ \(0\)\
\-\ ct\\:\\ 0\\.02908110100784612\ \(0\)\
\-\ this\\:\\ 0\\.026247816071574646\ \(0\)\
\-\ left\\:\\ 0\\.02605713991945373\ \(0\)\
\-\ right\\:\\ 0\\.025325322995824687\ \(0\)\
